Dimia tabs 3mg + 0.02mg #84


  • Availability: In Stock

  • 2 or more $55.20
  • 3 or more $54.40

Instruction for Dimia

Reed more and buy Dimia on this page

Dimia is a monophasic oral contraceptive.

Composition and form of release

The tablets are produced, film-coated.
The following active ingredients are present in 1 tablet of Dimia: 20 μg of ethinylestradiol and 3 mg of drospirenone. Also, the preparation contains such additional substances: magnesium stearate, pregelatinized corn starch, lactose monohydrate, copolymer of polyvinyl alcohol and macrogol.
The drug is produced in blisters of 28 tablets.

Pharmacological action

The drug Dimia contains ethinyl estradiol and drospirenone. Drospirenone is pharmacologically comparable to natural progesterone. It does not possess antiglucocorticoid, glucocorticoid and estrogenic activity and has a pronounced antiandrogenic and moderate antimineralocorticoid effect.
The contraceptive effect of the drug Dimia is based on its ability to slow down the onset of ovulation, improve the endometrium and increase the viscosity of the secretory fluid of the cervix.
According to reviews, Dimia is a very effective contraceptive.

Indications for use

In the instructions of Dimia, it is indicated that tablets are indicated for women of childbearing age for oral contraception.

Method of administration and dosage regimen

The tablets must be taken every day at about the same time. The tablets are taken in the order indicated on the blister pack and washed down with a little water. Duration of admission is 28 days, 1 tablet per day. Taking pills from the previous package must be started. As a rule, bleeding begins 2-3 days after the start of taking placebo tablets (last row).


According to the instructions, Dimia, like other combined contraceptive drugs, is contraindicated in the following cases:
    any conditions preceding thrombosis (including angina pectoris, transient ischemic attacks);
    venous and arterial thrombosis and thromboembolism (including stroke, myocardial infarction, deep vein thrombophlebitis, cerebrovascular disorders, pulmonary embolism);
    hereditary or acquired tendency to develop arterial or venous thrombosis;
    various risk factors that contribute to the development of arterial or venous thrombosis (arterial hypertension, cerebrovascular disease, damage to the valvular apparatus of the heart, smoking after 35 years of age, obesity, etc.);
    acute or severe chronic renal failure;
    pancreatitis with severe hypertriglyceridemia;
    vaginal bleeding of an unexplained nature;
    liver tumor, benign or malignant;
    the presence of any severe liver disease;
    the period of breastfeeding (negatively affects the amount and composition of milk);
    hormone-dependent malignant tumors of the breast or genital organs;
    hypersensitivity to one or more components of the drug;
    pregnancy or suspicion of it;
    lactose intolerance, lack of lactase;
    migraine with focal neurological symptoms.
According to reviews, Dimia should be prescribed with great care in the following cases:
    hereditary angioedema;
    postpartum period;
    diseases that contribute to the violation of peripheral circulation (systemic lupus erythematosus, diabetes mellitus, ulcerative colitis, Crohn's disease, phlebitis of superficial veins, hemolytic uremic syndrome, sickle cell anemia);
    diseases that developed during pregnancy or against the background of a previous intake of sex hormones (jaundice, chorea, atherosclerosis with hearing impairment, herpes, porphyria, chloasma).

Side effects

According to reviews, Dimia can cause the following undesirable side effects:
    Lymphatic and hematopoietic system: thrombocytopenia, anemia.
    Metabolism: anorexia, weight loss or weight gain, increased appetite, hyponatremia, hyperkalemia.
    Infections: candidiasis.
    Immune system: development of various allergic reactions.
    Nervous system: dizziness, headache, paresthesia, tremor, vertigo, depression, insomnia, anorgasmia, drowsiness, decreased libido.
    Cardiovascular system: varicose veins, migraine, epistaxis, tachycardia, fainting, increased blood pressure.
    Digestive system: diarrhea, vomiting, nausea, abdominal pain.
    Musculoskeletal system: pain in the limbs and back, muscle cramps.
    On the part of the skin and subcutaneous tissue: itching, rash, eczema, dry skin, skin striae, contact dermatitis.
    Biliary tract and liver: cholecystitis, soreness of the gallbladder.
    Reproductive system: chest pain, no bleeding, breast enlargement, pelvic pain, vaginitis, vaginal discharge, heavy or little bleeding, dry vaginal mucosa, cervical polyps, cyst or breast hyperplasia.


To date, there have been no reports of Dimia regarding an overdose. According to the general experience of taking oral contraceptives, Dimia tablets can cause symptoms of overdose such as nausea, vomiting, minor bleeding from the vagina.

The use of Dimia tablets during pregnancy and lactation

According to the instructions, Dimia is contraindicated during pregnancy and breastfeeding.
If pregnancy occurs while taking the tablets, then their further intake must be stopped immediately. According to epidemiological studies, taking Dimia, according to the instructions, does not have any negative consequences on the development of the fetus, however, undesirable effects that have a negative effect on the course of pregnancy cannot be ruled out.
According to reviews, Dimia negatively affects lactation, reduces the amount of breast milk and changes its composition, which has a negative effect on the baby. Therefore, it is advisable to stop breastfeeding while taking the drug.

Special instructions

It is necessary to start taking Dimia tablets only after examination and consultation with a doctor. If any undesirable effects occur while taking Dimia, a woman should immediately consult a doctor.

Storage conditions

Recommended shelf life of no more than 24 months.

Terms of sell

You don't need a prescription from a doctor to buy Dimia.